i2c Pharma have dedicated services to assist with the formulation development, optimisation and process for all inhalation dosage forms. The i2c approach utilises the principles of Quality by Design to ensure that a robust formulation can be manufactured. Our formulation development program ensures accelerated development through:

• Compatibility assessment and optimisation• Screening and selection• Device compatibility• Lab Pilot scale manufacturing• Accelerated stability

Our program design provides a wide selection of early formulations in a timely and cost effective manner, identifying lead candidates and expediting progress to clinical development.

What We Do